American Portfolios Advisors Charles River Laboratories International, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 1,661 shares of CRL stock, worth $327,200. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,661
Holding current value
$327,200
% of portfolio
0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$182.44 - $250.54 $303,032 - $416,146
1,661 New
1,661 $327 Million
Q2 2022

Mar 20, 2023
BUY
$204.13 - $302.4 $6,940 - $10,281
34 Added 2.05%
1,695 $363 Million
Q1 2022

Mar 21, 2023
BUY
$255.51 - $362.11 $297,924 - $422,220
1,166 Added 70.2%
2,827 $803 Million
Q4 2021

Mar 21, 2023
BUY
$351.38 - $448.68 $643,728 - $821,981
1,832 Added 110.3%
3,493 $1.32 Billion
Q3 2021

Mar 22, 2023
BUY
$372.64 - $458.3 $557,842 - $686,075
1,497 Added 90.13%
3,158 $1.3 Billion
Q2 2021

Mar 22, 2023
BUY
$294.17 - $371.65 $468,024 - $591,295
1,591 Added 95.79%
3,252 $1.2 Billion
Q1 2021

Mar 22, 2023
BUY
$249.67 - $299.48 $355,530 - $426,459
1,424 Added 85.73%
3,085 $894 Million
Q4 2020

Mar 22, 2023
BUY
$222.0 - $252.62 $230,436 - $262,219
1,038 Added 62.49%
2,699 $674 Million
Q3 2020

Mar 22, 2023
BUY
$175.56 - $226.45 $155,195 - $200,181
884 Added 53.22%
2,545 $576 Million
Q2 2020

Mar 24, 2023
BUY
$118.84 - $189.72 $139,042 - $221,972
1,170 Added 85.65%
2,536 $442 Million
Q1 2020

Mar 24, 2023
SELL
$98.9 - $178.34 $29,175 - $52,610
-295 Reduced 17.76%
1,366 $172 Million
Q4 2019

Mar 24, 2023
SELL
$126.05 - $152.76 $8,067 - $9,776
-64 Reduced 3.85%
1,597 $244 Million
Q3 2019

Mar 24, 2023
BUY
$125.07 - $143.67 $6,003 - $6,896
48 Added 3.26%
1,521 $201 Million
Q2 2019

Mar 24, 2023
SELL
$123.4 - $148.55 $23,199 - $27,927
-188 Reduced 11.32%
1,473 $209 Million
Q1 2019

Mar 24, 2023
BUY
$104.82 - $146.73 $9,119 - $12,765
87 Added 6.44%
1,437 $209 Million
Q4 2018

Mar 24, 2023
SELL
$105.09 - $137.23 $8,091 - $10,566
-77 Reduced 5.4%
1,350 $153 Million
Q3 2018

Mar 24, 2023
SELL
$112.11 - $134.54 $26,233 - $31,482
-234 Reduced 14.09%
1,427 $192 Million
Q2 2018

Mar 24, 2023
SELL
$102.37 - $117.25 $1,637 - $1,876
-16 Reduced 1.11%
1,427 $160 Million
Q1 2018

Mar 24, 2023
SELL
$98.19 - $115.2 $21,405 - $25,113
-218 Reduced 13.12%
1,443 $154 Million
Q4 2017

Mar 24, 2023
SELL
$100.43 - $118.09 $34,849 - $40,977
-347
1,314 $144 Million

Others Institutions Holding CRL

# of Institutions
732
Shares Held
51.8M
Call Options Held
233K
Put Options Held
236K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email